Investor
Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 436 (TSXV: $KHRN.V)
(OTC: $EDXC)
Delta, Kelowna, BC, July 2, 2020 (Investorideas.com Newswire)
www.Investorideas.com, a global news source covering leading sectors including marijuana
and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few public company announcements.
Khiron
Life Sciences Corp. (TSXV:
KHRN) (OTCQX:
KHRNF), a vertically integrated cannabis leader with core
operations in Latin America and Europe, announced
that
it has signed a distribution deal for its Kuida™ CBD cosmeceutical brand with
Red Yellow Red, a leading EU distributor of cosmetic products. Kuida skin and
body care products for women will be distributed by Red Yellow Red through four
major multinational drug store health and beauty distribution groups in Spain.
"The European skincare market
is the largest in the world, and as we scale up our EU activity this agreement
immediately expands our Kuida footprint into a €1.5 billion market. Red Yellow
Red have a large and compelling distribution network, and a robust sales and
education program that aligns with our proven market entry approach to help
more consumers integrate Kuida into their daily skincare regimen,"
comments Tejinder Virk, President, Khiron Europe.
Red Yellow Red is a specialized
distributor of cosmetic, beauty, lifestyle and personal wellbeing products
operating in Spain and Portugal, with access to 20,000 points of sale through
four drug store health and beauty distributor groups. To support Kuida sales
and brand image, Red Yellow Red will initiate training of retail staff on the
current Kuida portfolio, the benefits of cannabidiol (CBD), as well as the
brand's unique CBDERM™ technology.
"At Red Yellow Red we look to
bring innovative and first to market products to our distribution partners and
in turn, consumers. Kuida fits that model and is an established skincare brand
with an attractive CBD product line that, supported by our training and
education program, can have strong appeal across our Spanish pharmacy
network," comments José Luis Ganado, Managing Director, Red Yellow Red.
Ikänik
Farms, Inc. announced that it has purchased all issued and
outstanding shares of Delta 9 Corporation Mexico S.A. de C.V ("D9C"),
based in Coyoacán, Mexico. D9C's legal representative is permitted to import
and register cannabis seeds for cultivation through the legalized Amparo process.
The Company intends to contract-produce for national and international
pharmaceutical cannabis and hemp-derived CBD clients.
"I am very excited to welcome
D9C and its team of scientific, legal, and regulatory specialists who have been
exemplary leaders, shepherding the cannabis legalization process, and providing
Ikänik the opportunity to be a 1 of 1 in Mexico", said Brian Baca, CEO of
Ikänik Farms, Inc.
D9C is the exclusive Amparo
representative to import, cultivate, and produce products derived from cannabis
and hemp for national and international markets.
Borja Sanz de Madrid, President of
Ikänik International, Inc. further emphasized, "We are proud to
participate in this historic moment for Mexico. It will be our honor bringing
pharmaceutical cannabis Hecho en Mexico para el mundo"
Upon D9C's legal representative
completing the seed importation and registration process, cultivation and
facility construction will commence, providing employment opportunities and
social support in the communities it serves.
This acquisition marks a significant
milestone for the Company, as it continues to grow its multi-national operating
presence and prepares to complete a public listing on the Canadian Securities
Exchange.
Endexx
Corporation (OTC:EDXC), a lifestyle company
focused on the intersection of science, compliance, and formulation of
innovative phytonutrient-based food and nutritional products, today
announced the launch of the Company’s newest product line,
Phyto-Drops CBD for Pets. The new line complements the PhytoBites soft chews
introduced in 2016 to build a strong suite of Pet products.
“We
continued to build, research, and develop new products as R&D is rooted in
the DNA of our Company,” commented Endexx Chief Executive Officer and Chairman,
Todd Davis. “Our drops are formulated using all-natural ingredients and
flavored with natural oils and no sugar. We are thrilled to bring this product
to market as our pet division continues to lead product demand. With the shift in
consumer buying preferences amid the pandemic, this product line will initially
be available online through our website followed by our wholesale network.
Products with all-natural ingredients and no sugar provide assurance of quality
and purity for dogs, cats, and their families.
Our complete formulations help to improve our customer’s and their pet’s
“Quality of Life”. We continue to remain focused on consumer-centered
innovation and this product launch is a reflection of our commitment to our
customers.”
Phyto-Drops
CBD for Pets are now available in 30ml and 10ml formats on CBD Unlimited’s
e-commerce website. CBD Unlimited oils are free from any synthetic additives
and each product is lab tested to ensure quality of the product. Phyto-Drops
CBD for Pets is formulated for minimal dosing and long-lasting results.
To
purchase Phyto-Drops CBD for Pets, please visit https://www.cbdunlimited.com/our-products/buy-cbd/pets/
Hemp,
Inc. (OTC: HEMP)
announced
its support for new guidelines from the U.S. Treasury Department’s Financial
Crimes Enforcement Network.
“These
guidelines help clarify how hemp should be treated and operate in the banking
space. This is an important move by the US Department of Treasury in support of
the American hemp industry,” said Hemp, Inc. CEO Bruce Perlowin. “A lot of the
hurdles that the hemp industry faces come from stigma and misinformation; in
the past that has informed policy. Fortunately, the power and promise of hemp
is coming to light in the mainstream and we are gaining lots of support from
everyday people, regulatory professionals and policy makers.”
The
Financial Crimes Enforcement Network’s (FinCEN) new guidelines emphasize that
hemp businesses must be treated equally. This means that financial institutions
are expected to monitor the transactions made by hemp-related businesses as
they would for other clients. The FinCEN instructs the financial institutions
to follow standard procedures and file a SAR (Suspicious Activity Report) only
if they have been made aware of suspicious activity.
According
to the FinCEN, suspicious activity could include:
● A customer appears to be engaged in hemp
production in a state or jurisdiction in which hemp production remains illegal.
●
A customer appears to be using a
state-licensed hemp business as a front or pretext to launder money derived
from other criminal activity or derived from marijuana-related activity that
may not be permitted under applicable law.
●
A customer engaged in hemp production seeks to
conceal or disguise involvement in marijuana-related business activity.
● The customer is unable or unwilling to certify
or provide sufficient information to demonstrate that it is duly licensed and
operating consistent with applicable law, or the financial institution becomes
aware that the customer continues to operate after a license revocation, or
inconsistently with applicable law.
Additionally,
FinCEN provided clarification on requirements for businesses that are involved
in both hemp and marijuana, stressing the importance of keeping the proceeds of
the businesses separate and ensuring that the customer and its financial
institution are able to distinguish which proceeds are marijuana-related and
which are hemp-related.
Those
interested in King of Hemp™ pre-rolls or hemp-derived CBD tinctures should
visit www.kingofhempusa.com or
email sales@kingofhempusa.com
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com
website and that this podcast is not an endorsement to buy products or services
or securities. Investors are reminded all investment involves risk and possible
loss of investment.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy:
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Contact Investorideas.com
800
665 0411
No comments:
Post a Comment